Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective December 13, 2019, the Board of Directors (the "Board") of Acadia Healthcare Company, Inc., a Delaware corporation ("Acadia" or the "Company") increased the number of Class II directors serving on the Board from two to three and elected Jason R. Bernhard to fill the vacancy created by the increase in the number of Class II directors. The term of office of Class II directors expires at the Company's annual meeting of stockholders in 2022. The Board has not named Mr. Bernhard to any committees of the Board, but expects to do so at a future meeting.

Mr. Bernhard is the Chief Operating Officer, Financial Advisory North America; Managing Director, Head of North America Healthcare Investment Banking; and a Vice Chairman of Investment Banking at Lazard Ltd. Mr. Bernhard earned a Bachelor of Arts degree from the University of Pennsylvania in 1988 and an MBA from The Wharton School at the University of Pennsylvania in 1993.

Mr. Bernhard will receive compensation for his service to the Company in accordance with the Company's existing compensation plan for nonemployee directors. Information with respect to the director compensation plan is set forth in the definitive proxy statement for the Company's 2019 annual meeting of stockholders, filed with the SEC on March 21, 2019.

A copy of the press release announcing Mr. Bernhard's election to the Board is filed as Exhibit 99 to this report.




Item 9.01.    Financial Statements and Exhibits.

   (d)        Exhibits.

    99          Press Release of Acadia Healthcare Company, Inc., dated December 17,
              2019.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses